A-21
Immunity and Regeneration Integration Unit
6F
0604, 0912B
New drugs for refractory neurological diseases through translational research
・Search for biomarkers of the state of refractory neurological diseases and effect of drug treatment
・Basic research on drug development for refractory neurological diseases
・Search for new drug targets in refractory neurological diseases
Frustratingly, little is known about the causes of many neurological diseases and little is available in terms of treatment. In this course, we examine the pathology of several neurological diseases, the use of animal models to study the disease, and consider potential drug targets and biomarkers. Studies involve basic and clinical research.
Responsible Department
Department of Neuro-Medical Science
Research Partner
Mitsubishi Tanabe Pharma Corporation
Project Members
Principal Investigator
Professor
Department of Molecular Neuroscience
Specially Appointed Professor
Department of Neuro-Medical Science
Members
Specially Appointed Assistant Professor
Department of Neuro-Medical Science
Specially Appointed Assistant Professor
Department of Neuro-Medical Science
Specially Appointed Assistant Professor
Department of Neuro-Medical Science
Specially Appointed Researcher
Department of Neuro-Medical Science
Joint Research Collaborator
Mitsubishi Tanabe Pharma Corporation
Joint Research Collaborator
Mitsubishi Tanabe Pharma Corporation
Joint Research Collaborator
Mitsubishi Tanabe Pharma Corporation
Joint Research Collaborator
Mitsubishi Tanabe Pharma Corporation
Joint Research Collaborator
Mitsubishi Tanabe Pharma Corporation
Joint Research Collaborator
Mitsubishi Tanabe Pharma Corporation
Links
Department of Molecular Neuroscience, Graduate School of Medicine, Osaka University
https://www.med.osaka-u.ac.jp/pub/molneu/index_e.html
Mitsubishi Tanabe Pharma Corporation
https://www.mt-pharma.co.jp/e/